| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 56 |
| 1 | ETOPOSIDE | 49 |
| 2 | CYCLOPHOSPHAMIDE | 48 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 48 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 48 |
| 5 | BEVACIZUMAB | 47 |
| 6 | PACLITAXEL | 44 |
| 7 | PREDNISONE | 44 |
| 8 | NIVOLUMAB | 40 |
| 9 | DEXAMETHASONE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIV-AFLIBERCEPT | 5 | 0.0038 |
| 1 | VINORELBINE | 14 | 0.0020 |
| 2 | DEFLAZACORT | 5 | 0.0019 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 6 | 0.0013 |
| 4 | ALGLUCOSIDASE ALFA | 3 | 0.0012 |
| 5 | COAGULATION FACTOR VIIA (RECOMBINANT) | 3 | 0.0011 |
| 6 | ERIBULIN MESYLATE | 4 | 0.0011 |
| 7 | LAPATINIB | 16 | 0.0010 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 9 | BRIGATINIB | 3 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 3 | 0.0009 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 66 | 0.0007 |
| 5 | Topoisomerase Inhibitor [EPC] | 51 | 0.0007 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 14 | 0.0006 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 8 | Human Immunoglobulin G [EPC] | 11 | 0.0005 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |